Summary of Classification and Labelling
Notified classification and labelling
General Information
236-938-4 |
Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo- |
13553-79-2 |
Notified classification and labelling according to CLP criteria
STOT SE 2 |
H371
(liver)
|
H371
|
|
GHS08 GHS09 Wng
|
|
|
|
|
2 |
|
View details
|
Aquatic Acute 1 |
H400
|
|
Aquatic Chronic 1 |
H410
|
H410
|
Acute Tox. 4 |
H302
|
H302
|
|
GHS07 Wng
|
|
|
|
|
2 |
|
View details
|
STOT SE 2 |
H371
(Organs)
|
H371
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
Number of Aggregated Notifications: 3